Zdrowie i gospodarka · 13/04/1999

FDA Proposes to Revoke Patient Labeling Requirement for Progestational Drug Products

The US Food and Drug Administration (FDA) is proposing to remove its requirement for patient labeling on progestational drug products, citing a lack of scientific evidence supporting the need for such labeling, and instead plans to provide more tailored labeling for specific drug products.